Hetemcit Tablet is a medicine brand authorised in South Africa. This page provides limited product identification information only .
Medicine name : Hetemcit Tablet
Country: South Africa
Schedule: S4
Active ingredients :
| Active ingredient | EACH TABLET CONTAINS |
|---|---|
| EMTRICITABINE | 200,0 mg |
| TENOFOVIR DISOPROXIL FUMARATE | 300,0 mg |
| Sugar | Lactose Monohydrate 80 mg |
Hetemcit Tablet is a scheduled medicine in South Africa. Detailed information, including its uses, warnings, precautions, dosage guidance and possible side effects, is intended only for registered healthcare professionals or for patients to whom the medicine has been legally prescribed.
This page does not provide medical advice, treatment recommendations, promotional claims, or instructions for use. Please consult a registered doctor, pharmacist, or other qualified healthcare professional for information specific to your condition and prescription.
For your safety, do not use Hetemcit Tablet unless it has been prescribed or supplied to you in accordance with South African medicine regulations.
Manufacturer/holder
Hetero Drugs South Africa (Pty) Ltd
SAHPRA / product identifier : 47/20.2.8/0232
Sources
Written by: RxZest Editorial Team
Editorial review: Checked for readability, structure, and source alignment
Based on SAHPRA-approved information : Hetemcit Tablet
Last updated: [06/05/2026]
